Triptan drugs, natural killer cell cytotoxicity, and neutrophils pro-matrix metalloproteinase-9 secretion

Headache

Volumn 48, Issue 10, 2008, Pages 1482-1489

  Puente, Javier ^b   Jaque, Maria ^b   Carrasco, Carolina ^b   Cruz, Carlos ^b   Valenzuela, Maria ^b   Wolf, Marion ^c   Mosnaim, Aron ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c International Neuropsychiatry Consultants   (United States)

Author keywords

Benzopyran; Inflammation; Natural killer cell activity; Neutrophils; Pro matrix metalloproteinase 9 secretion; Triptan drugs

Indexed keywords

ALNITIDAN; ANTIMIGRAINE AGENT; AVITRIPTAN; CHROMIUM 51; GELATINASE B; NARATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD BANK; BLOOD SAMPLING; CELL ACTIVITY; CELL STRAIN K 562; CENTRIFUGATION; CYTOTOXICITY; DENSITOMETRY; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; IMMUNOMAGNETIC SEPARATION; INFLAMMATION; INNATE IMMUNITY; MALE; MIGRAINE; MOLECULAR WEIGHT; NATURAL KILLER CELL; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SUPERNATANT; ZYMOGRAPHY;

ADULT; BENZOPYRANS; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOLECULAR STRUCTURE; NEUTROPHILS; PIPERIDINES; SUMATRIPTAN; TRYPTAMINES;

EID: 56549108090     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01136.x     Document Type: Article

References (41)

1. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 4th edn. Philadelphia, PA : Saunders Co 2000 : 17 38, 235 269.
2. Farag S, Van Deusen J, Fheninger T, Caligiuri M. Biology and clinical impact of human natural killer cells. Int J Hematol. 2003 78 : 7 17.
3. Young HA, Ortaldo J. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res. 2006 16 : 20 24.
4. Naume B, Espevik T. Immunoregulatory effects of cytokines on natural killer cells. Scand J Immunol. 1994 40 : 128 134.
5. Mosnaim AD, Diamond S, Wolf ME, Puente J, Freitag F. Endogenous opioid-like peptides in headache. An overview. Headache. 1990 29 : 368 372.
6. Puente J, Blanco L, Montoya M, et al. Effect of salmonella typhi wild type and O-antigen mutants on human natural killer cell activity. Int J Immunopharmacol. 2000 22 : 355 364.
7. Xiao L, Eneroth P. Tricyclic antidepressants inhibit human natural killer cells. Toxicol Appl Pharmacol. 1996 137 : 157 162.
8. Takagi S, Kitagawa S, Oshimi K, Takaku F, Miura Y. Effect of local anaesthetics on human natural killer cell activity. Clin Exp Immunol. 1983 53 : 477 481.
9. Tanaka T, Porter CM, Horvath-Arcidiacono JA, Bloom ET. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis. Int Immunol. 2007 2 : 163 173.
10. Whalen MM, Bankhurst AD. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J. 1990 272 : 327 331.
11. Yeager MP, Procopio M, DeLeo J, Arruda J, Hildebrandt L, Howell A. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16+ lymphocytes in humans. Anesth Analg. 2002 94 : 94 99.
12. Markasz L, Stuber G, Vanherberghen B, et al. Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. Mol Cancer Ther. 2007 2 : 644 654.
13. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of drug reactions. The initiation and propagation of immune responses elicited by drug treatment. Drug Saf. 2000 23 : 483 507.
14. Bugelski PJ. Genetic aspects of immune mediated adverse drug effects. Nat Rev Drug Discov. 2005 4 : 59 69.
15. Saxena PR, Tfelt-Hansen P. Triptans, 5-HT1B/1D receptor agonists in the acute treatment of migraines. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 469 503.
16. Jaque MP, Llanos D, Miranda D, Gamonal J, Valenzuela MA, Puente J. Regulación de la citotoxicidad y secrecion de metaloproteinasas de matriz extracelular (MMP) de celulas sanguineas mononucleares (CMN). IV Jornadas de Investigación de Ciencia y Tecnología. Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, 2003.
17. Pugin G, Widmer MC, Kossodo S, Liang C, Preas H, Suffredini A. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol. 1999 20 : 458 464.
18. Hibbs M, Hasty K, Seyer J, Kang H, Mainardi C. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem. 1985 260 : 24493 22500.
19. Naume B, Gately M, Espevik T. A comparative study of IL-12, IL-7 induced effects on immunomagnetically purified CD56+ NK cells. J Immunol. 1992 148 : 2429 2436.
20. Rose N, de Macario EC, Fohey J, Friedman H, Penn G. Manual of Clinical Laboratory Immunology, 4th edn. Washington, DC : American Society for Microbiology 1992 : 926 928.
21. Kettlun A, Collados L, García L, et al. Matrix metalloproteinase profile in patients with Cruztfeld-Jacob disease. Int J Clin Pract. 2003 57 : 475 478.
22. Sanders-Bush E, Mayer S. 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In : Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Bases of Therapeutics, 11th edn. New York : McGraw Hill 2006 297 315.
23. Galbiati E, Caruso PL, Amari G, et al. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen. J Pharmacol Exp Therap. 2002 303 : 196 203.
24. Hoffmann O, Keilwerth N, Bille MB, et al. Triptans reduce the inflammatory response in bacterial meningitis. J Cereb Blood Flow Metab. 2002 22 : 988 996.
25. Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech. 2001 53 : 167 178.
26. Hellstrand K, Hermodsson S. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J Immunol. 1987 139 : 869 875.
27. Kloppenburg M, Brinkman BM, de Rooij-Dijk HH, et al. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemothr. 1996 40 : 934 940.
28. Fukuzawa M, Satoh J, Ohta S, et al. Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs. Immunopharmacol. 2000 48 : 65 74.
29. Goldring JP, Nemaorani S. Antimalarial drugs modulate the expression of monocyte receptors. Int J Immunopharmacol. 1999 21 : 599 607.
30. Muller K, Gram J, Bollerslev J, et al. Down-regulation of monocyte functions by treatment of healthy adults with 1-alpha, 25dihydroxyvitamin D3. Int J Immunopharmacol. 1991 13 : 525 530.
31. Filep JG, Beauchamp M, Baron C, Paquette Y. Peroxinitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood. J Immunol. 1998 161 : 5656 5662.
32. Driessen C, Hirv K, Rink L, Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 1994 13 : 15 20.
33. Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol. 1996 156 : 42 47.
34. Kono K, Salazar-Onfray F, Petersson M, et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal transducing zeta molecules and inhibits tumor - specific T cell and natural killer cell mediated cytotoxicity. Eur J Immunol. 1996 26 : 1308 1313.
35. Ford Bainton D. Developmental biology of neutrophils and eosinophils. In : Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates, 3rd edn. Philadelphia, PA : Lippincott Williams & Willkins 1999 : 13 34.
36. Delclaux C, Delacourt C, d'Ortho M, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polumorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol. 1996 14 : 288 295.
37. Strausbaugh H, Rosen S. A potential role for annexin 1 as a physiologic mediator of glucocorticoid induced L-selectin shedding from myeloid cells. J Immunol. 2001 166 : 6294 6300.
38. Ottonello L, Arduino N, Bertolotto M, Dapino P, Mancini M, Dallegri F. In vitro inhibition of human neutrophil histotoxicity by ambroxol: Evidence for a multistep mechanism. Br J Pharmacol. 2004 140 : 736 742.
39. Silva SO, Rodrigues MR, Ximenes VF, Bueno-da-Silva AEB, Amarante-Mendes GP, Campa A. Neutrophils as a specific target for melatonin and kyrunamines: Effects on cytokine release. J Neuroimmunol. 2004 156 : 146 152.
40. Leira R, Sobrino T, Rodríguez-Yáñez M, Blanco M, Arias S, Castillo J. MMP-9 immunoreactivity in acute migraine. Headache. 2007 47 : 698 702.
41. Imamura K, Takeshima T, Fusayasu E, Nakashima K. Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache. 2008 48 : 135 139.